ClinicalTrials.gov
public full text
Public Domain
RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.
This is a multicenter, observational real world clinical trial with prospective follow up that will evaluate the treatment outcome of Acute Myeloid Leukemia (AML) patients in the first line with intensive chemotherapy based regimens in Argentina.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old#907084
- Efficacy of FLAG Regimen for the Treatment of Patients With AML#1127539
- DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML#1140433
- Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia#1058228
- Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia#1164506
Record · ID 910351
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive